SUTURTEK ANNOUNCES SERIES B FINANCING

SuturTek, a venture-funded medical device company developing patented safe-suturing devices, recently closed its Series B Financing. The company plans to use the funds from this financing to begin commercializing its portfolio of advanced suturing devices addressing a combined market opportunity exceeding $4 billion worldwide. SuturTek's first product, for sternum closure following open-heart surgery, is scheduled for market introduction in 2005.

Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20050104005080&newsLang=en)